Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Tuberculosis (Edinb) ; 95(1): 40-7, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25476870

ABSTRACT

BACKGROUND: The role of B cells in human host response to Mycobacterium tuberculosis (Mtb) infection is still controversial, but recent evidence suggest that B cell follicle like structures within the lung may influence host responses through regulation of the local cytokine environment. A candidate for such regulation could be the chemokine CXCL10. CXCL10 is mainly produced by human monocytes, but a few reports have also found CXCL10 production by human B cells. The objective of this study was to investigate CXCL10 production by human B cells in response to in vitro stimulation with Mtb antigens. METHODOLOGY/PRINCIPAL FINDINGS: We analyzed human blood samples from 30 volunteer donors using multiparameter flow cytometry, and identified a subgroup of B cells producing CXCL10 in response to in vitro stimulation with antigens. T cells did not produce CXCL10, but CXCL10 production by B cells appeared to be mediated via IFN-γ and dependent on contact with antigen-specific T cells recognizing the antigen. CONCLUSION: Human B cells are able to produce CXCL10 in an IFN-γ and T cell contact-dependent manner. The present findings suggest a possible mechanism through which B cells in part may influence granuloma formation in human tuberculosis (TB) and participate in infection control.


Subject(s)
B-Lymphocyte Subsets/metabolism , Chemokine CXCL10/biosynthesis , T-Lymphocyte Subsets/immunology , Tuberculosis/immunology , Antigens, Bacterial/immunology , Cells, Cultured , Dose-Response Relationship, Drug , Granuloma/immunology , Healthy Volunteers , Humans , Immunity, Cellular/immunology , Immunologic Factors/pharmacology , Interferon-alpha/pharmacology , Interferon-gamma/pharmacology , Mycobacterium tuberculosis/immunology
SELECTION OF CITATIONS
SEARCH DETAIL